Managing Pre-Market vs Post-Market Diagnostic Approvals
Managing Pre-Market vs Post-Market Diagnostic Approvals Strategies to Manage Pre- and Post-Market Approvals for Companion Diagnostics Understanding the Regulatory Lifecycle of a Companion Diagnostic Companion diagnostics (CDx) are essential tools for personalized medicine. From initial clinical validation to ongoing performance monitoring, CDx developers must address both pre-market and post-market regulatory requirements. Each stage comes with…
Read More “Managing Pre-Market vs Post-Market Diagnostic Approvals” »